Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Medicure Gross Profit 2010-2023 | MCUJF

Medicure gross profit from 2010 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  
Medicure Annual Gross Profit
(Millions of US $)
2023 $10
2022 $12
2021 $10
2020 $4
2019 $10
2018 $19
2017 $18
2016 $21
2015 $16
2014 $
2013 $4
2012 $2
2011 $4
2011 $
2010 $3
2010 $
2009 $3
2009 $
Medicure Quarterly Gross Profit
(Millions of US $)
2023-12-31 $2
2023-09-30 $3
2023-06-30 $3
2023-03-31 $3
2022-12-31 $3
2022-09-30 $3
2022-06-30 $3
2022-03-31 $3
2021-12-31 $3
2021-09-30 $2
2021-06-30 $2
2021-03-31 $2
2020-12-31 $0
2020-09-30 $2
2020-06-30 $1
2020-03-31 $1
2019-12-31 $0
2019-09-30 $3
2019-06-30 $4
2019-03-31 $3
2018-12-31 $5
2018-09-30 $5
2018-06-30 $5
2018-03-31 $4
2017-12-31 $-2
2017-09-30 $5
2017-06-30 $11
2017-03-31 $5
2016-12-31 $7
2016-09-30 $6
2016-06-30 $5
2016-03-31 $4
2015-12-31 $7
2015-09-30 $4
2015-06-30 $3
2015-03-31 $3
2014-09-30 $2
2014-06-30 $2
2014-03-31 $1
2013-12-31 $1
2013-09-30 $1
2013-06-30 $1
2013-03-31 $0
2012-12-31 $1
2012-09-30 $1
2012-06-30 $0
2012-03-31 $0
2012-02-29
2011-12-31 $2
2011-09-30 $1
2011-06-30 $1
2011-03-31 $1
2010-12-31 $1
2010-09-30 $1
2010-06-30
2010-03-31 $0
2009-12-31 $1
2009-09-30 $1
2009-06-30
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.008B $0.016B
Medicure Inc is a cardiovascular drug discovery and development company focused on developing effective therapeutics for unmet needs in the field of cardiovascular medicine. In addition to MC-4232, they are also conducting Phase II clinical trials with MC-1, which is focused on the prevention and treatment of ischemia, ischemic reperfusion injury, and stroke.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.595B 28.19
Chugai Pharmaceutical (CHGCY) Japan $54.482B 23.66
Takeda Pharmaceutical (TAK) Japan $42.314B 6.86
Merck (MKGAF) Germany $21.132B 19.94
Astellas Pharma (ALPMY) Japan $17.282B 24.49
Shionogi (SGIOY) Japan $14.459B 12.51
Neurocrine Biosciences (NBIX) United States $13.400B 55.65
Sandoz Group AG (SDZNY) $12.650B 0.00
United Therapeutics (UTHR) United States $10.945B 11.72
Catalent (CTLT) United States $10.176B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.599B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.967B 7.07
Ionis Pharmaceuticals (IONS) United States $6.084B 0.00
Revolution Medicines (RVMD) United States $5.940B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.341B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Madrigal Pharmaceuticals (MDGL) United States $4.708B 0.00
Alpine Immune Sciences (ALPN) United States $4.219B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.103B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.060B 0.00
Indivior (INDV) United States $2.664B 12.39
Evotec AG (EVO) Germany $2.583B 0.00
Summit Therapeutics (SMMT) United States $2.572B 0.00
Corcept Therapeutics (CORT) United States $2.434B 24.75
Dyne Therapeutics (DYN) United States $2.228B 0.00
PTC Therapeutics (PTCT) United States $2.024B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.973B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.805B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.796B 18.56
NewAmsterdam Pharma (NAMS) Netherlands $1.759B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.695B 10.04
Ardelyx (ARDX) United States $1.643B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.580B 27.66
Avadel Pharmaceuticals (AVDL) Ireland $1.448B 0.00
4D Molecular Therapeutics (FDMT) United States $1.348B 0.00
Xencor (XNCR) United States $1.252B 0.00
Pacira BioSciences (PCRX) United States $1.248B 12.42
Ironwood Pharmaceuticals (IRWD) United States $1.233B 11.59
Soleno Therapeutics (SLNO) United States $1.206B 0.00
Ocular Therapeutix (OCUL) United States $1.188B 0.00
Collegium Pharmaceutical (COLL) United States $1.168B 7.19
Centessa Pharmaceuticals (CNTA) United Kingdom $1.135B 0.00
Cassava Sciences (SAVA) United States $0.984B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.983B 0.00
Cronos Group (CRON) Canada $0.959B 0.00
Sage Therapeutics (SAGE) United States $0.928B 0.00
Relay Therapeutics (RLAY) United States $0.922B 0.00
ARS Pharmaceuticals (SPRY) United States $0.870B 0.00
Enliven Therapeutics (ELVN) United States $0.869B 0.00
USANA Health Sciences (USNA) United States $0.846B 13.32
Lyell Immunopharma (LYEL) United States $0.765B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.738B 0.00
Savara (SVRA) United States $0.700B 0.00
Silence Therapeutics (SLN) United Kingdom $0.664B 0.00
Verve Therapeutics (VERV) United States $0.636B 0.00
Siga Technologies (SIGA) United States $0.626B 9.27
Korro Bio (KRRO) United States $0.601B 0.00
OmniAb (OABI) United States $0.591B 0.00
Altimmune (ALT) United States $0.566B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.566B 0.00
Exscientia (EXAI) United Kingdom $0.563B 0.00
Tourmaline Bio (TRML) United States $0.517B 0.00
KalVista Pharmaceuticals (KALV) United States $0.502B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.467B 0.00
Harrow (HROW) United States $0.447B 0.00
Larimar Therapeutics (LRMR) United States $0.444B 0.00
Heron Therapeutics (HRTX) United States $0.437B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.429B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.413B 0.00
Esperion Therapeutics (ESPR) United States $0.405B 0.00
Lexeo Therapeutics (LXEO) United States $0.403B 0.00
ProKidney (PROK) United States $0.401B 0.00
Organogenesis (ORGO) United States $0.380B 72.00
Bioventus (BVS) United States $0.362B 0.00
Nature's Sunshine Products (NATR) United States $0.358B 20.02
Enanta Pharmaceuticals (ENTA) United States $0.348B 0.00
ESSA Pharma (EPIX) Canada $0.343B 0.00
Metagenomi (MGX) United States $0.336B 0.00
Foghorn Therapeutics (FHTX) United States $0.316B 0.00
Lyra Therapeutics (LYRA) United States $0.315B 0.00
Fractyl Health (GUTS) United States $0.312B 0.00
Prelude Therapeutics (PRLD) United States $0.309B 0.00
Nektar Therapeutics (NKTR) United States $0.307B 0.00
Akebia Therapeutics (AKBA) United States $0.306B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Nanobiotix S.A (NBTX) France $0.287B 0.00
Aquestive Therapeutics (AQST) United States $0.287B 0.00
Pyxis Oncology (PYXS) United States $0.286B 0.00
Adherex Technologies (FENC) United States $0.284B 0.00
Black Diamond Therapeutics (BDTX) United States $0.271B 0.00
Xeris Biopharma Holdings (XERS) United States $0.268B 0.00
Telomir Pharmaceuticals (TELO) United States $0.266B 0.00
Avita Medical (RCEL) United States $0.254B 0.00
Century Therapeutics (IPSC) United States $0.253B 0.00
Aldeyra Therapeutics (ALDX) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Conduit Pharmaceuticals (CDT) United States $0.232B 0.00
Acrivon Therapeutics (ACRV) United States $0.226B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.210B 0.00
Zevra Therapeutics (ZVRA) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.193B 0.00
Incannex Healthcare (IXHL) Australia $0.189B 0.00
Regulus Therapeutics (RGLS) United States $0.183B 0.00
VAXART, INC (VXRT) United States $0.158B 0.00
CytoDyn (CYDY) United States $0.156B 0.00
GlycoMimetics (GLYC) United States $0.155B 0.00
Inotiv (NOTV) United States $0.154B 0.00
MediWound (MDWD) Israel $0.152B 0.00
Elite Pharmaceuticals (ELTP) United States $0.150B 14.00
Achieve Life Sciences (ACHV) Canada $0.149B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.142B 3.00
Karyopharm Therapeutics (KPTI) United States $0.140B 0.00
Relmada Therapeutics (RLMD) United States $0.140B 0.00
OptiNose (OPTN) United States $0.137B 0.00
FibroGen (FGEN) United States $0.128B 0.00
Cardiol Therapeutics (CRDL) Canada $0.127B 0.00
Citius Pharmaceuticals (CTXR) United States $0.125B 0.00
Eliem Therapeutics (ELYM) United States $0.119B 0.00
ProPhase Labs (PRPH) United States $0.118B 0.00
Vivani Medical (VANI) United States $0.114B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.103B 0.00
PMV Pharmaceuticals (PMVP) United States $0.092B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Journey Medical (DERM) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Assertio Holdings (ASRT) United States $0.082B 6.68
Carisma Therapeutics (CARM) United States $0.080B 0.00
Tempest Therapeutics (TPST) United States $0.080B 0.00
Mural Oncology (MURA) $0.071B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.057B 0.00
SCYNEXIS (SCYX) United States $0.055B 0.81
Gain Therapeutics (GANX) United States $0.051B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
Viracta Therapeutics (VIRX) United States $0.045B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
CASI Pharmaceuticals (CASI) China $0.035B 0.00
Nutriband (NTRB) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Protara Therapeutics (TARA) United States $0.034B 0.00
Lipocine (LPCN) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Aptorum Group (APM) United Kingdom $0.029B 0.00
Addex Therapeutics (ADXN) Switzerland $0.027B 0.00
CERo Therapeutics Holdings (CERO) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Alaunos Therapeutics (TCRT) United States $0.026B 0.00
JanOne (JAN) United States $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
DURECT (DRRX) United States $0.024B 0.00
Indaptus Therapeutics (INDP) United States $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.87
TherapeuticsMD (TXMD) United States $0.023B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Surrozen (SRZN) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.10
BioVie (BIVI) United States $0.020B 0.00
Talphera (TLPH) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Biomerica (BMRA) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Clever Leaves Holdings (CLVR) Canada $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
XORTX Therapeutics (XRTX) Canada $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Universe Pharmaceuticals INC (UPC) China $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Petros Pharmaceuticals (PTPI) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.17
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 47.40